Vik Peck
Public Communications Contact bij EUPRAXIA PHARMACEUTICALS INC.
Oorsprong van het eerstegraads netwerk van Vik Peck
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
19
| Extinct | Pharmaceuticals: Major | 19 |
| Public Company | Biotechnology | 13 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Vik Peck via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
AAIPharma, Inc.
 AAIPharma, Inc. Miscellaneous Commercial ServicesCommercial Services AAIPharma, Inc. provides product development services to the pharmaceutical, biotechnology and medical device industries. Its services include drug delivery technologies, contract manufacturing, clinical packaging and distribution and bioanalytical services. The company was founded in 1979 and is headquartered in Wilmington, NC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| PROGENICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MEDICURE INC. | Pharmaceuticals: Major | Public Communications Contact | |
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SANOFI | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| SONOMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Chief Executive Officer | |
| Queen's University | College/University | Undergraduate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| University of British Columbia | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Colorado Health Sciences Center | College/University | Corporate Officer/Principal | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Basel | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| University of Lausanne | College/University | Doctorate Degree Masters Business Admin | |
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | President Corporate Officer/Principal | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Chairman Chairman | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Chairman Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal General Counsel Human Resources Officer Public Communications Contact Human Resources Officer | |
OM Pharma SA
 OM Pharma SA Pharmaceuticals: MajorHealth Technology OM Pharma SA engages in manufacture of pharmaceutical products. Its portfolio includes products for respiratory tract infections, lower urinary tract infections, chronic venous insufficiency, microangiopathies, hemorrhoids, and menometrorrhagia. The company was founded by Jean-Rene Ricard in 1937 and is headquartered in Meyrin, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Biotechnology | Corporate Officer/Principal | |
Novartis Norge AS
 Novartis Norge AS Miscellaneous Commercial ServicesCommercial Services Novartis Norge AS develops, markets, and trades pharmaceuticals. It offers ophthalmic and generic products. The company is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Chief Executive Officer | |
European Research Council
 European Research Council Investment Trusts/Mutual FundsMiscellaneous The European Research Council is an organization that provides grants for research projects. The organization is based in Brussels, Belgium. As a grantee, individuals are required to submit scientific and financial reports for assessment by ERC Scientific Officers. The organization emphasizes the importance of research ethics and compliance with legislation, disciplinary norms, and protection of research subjects. The responsibility for ethics lies with the individuals conducting the research, while the formal accountability lies with the signatory of the Grant Agreement, the Host Institution. | Investment Trusts/Mutual Funds | Treasurer | |
Swissmedic
 Swissmedic Miscellaneous Commercial ServicesCommercial Services Swissmedic is the national authorisation and supervisory authority for drugs and medical products. It provides clinical laboratory testing services. The company is headquartered in Bern, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Centre Hospitalier Universitaire Vaudois
 Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Hospital/Nursing Management | Corporate Officer/Principal | |
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Investor Relations Contact | |
| University of Kansas Medical School | College/University | Doctorate Degree | |
| GALENICA AG | Medical Distributors | Director/Board Member Director/Board Member Chairman Chairman Director/Board Member | |
TMX Equicom, Inc.
 TMX Equicom, Inc. Miscellaneous Commercial ServicesCommercial Services Part of TMX Group Ltd., TMX Equicom, Inc. is a Canadian company that provides investor relations services. The company is based in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Accuro Technologies, Inc. | Director/Board Member Chairman Chief Executive Officer | ||
Opterion Health AG
 Opterion Health AG Medical/Nursing ServicesHealth Services Opterion Health AG is a Swiss company that focuses on bringing innovation to dialysis care and fostering home dialysis to improve the quality of life for patients suffering from end-stage renal disease (ESRD). Opterion Health is based in Muttenz, CH. The private company aims to increase the survival rates of people with ESRD and reduce healthcare costs. The company was founded in 2012 by Guido Grentzmann, and the CEO is Bjorn Englund. | Medical/Nursing Services | Chairman Director/Board Member | |
| Junior Achievement British Columbia | Director/Board Member Director/Board Member | ||
Actimed Therapeutics Ltd.
 Actimed Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Actimed Therapeutics Ltd. is a British clinical stage specialty pharmaceutical company that focuses on bringing innovation to the treatment of muscle wasting disorders. Actimed is based in Ascot, UK. Actimed's lead product, ACM-001 (S-pindolol), targets multiple biological pathways that drive cachexia and has generated promising proof of concept data in a phase II clinical trial in patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). The company is currently preparing for further clinical studies of cachexia in these two cancer types. The company was founded in 2017 by Stefan D. Anker and Andrew Justin Stewart Coats, two world-leading physicians in muscle wasting research, together with Yann Colardelle, a professional in communications and medical education. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Onycho Pharma Pte Ltd. | Chairman | ||
Vifor Pharma Asia Pacific Pte Ltd.
 Vifor Pharma Asia Pacific Pte Ltd. Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., Vifor Pharma Asia Pacific Pte Ltd. is a Singaporean company that manufactures iron, kidney, and cardio renal medicines. The company is based in Singapore, Singapore. | Pharmaceuticals: Major | Chief Executive Officer | |
| Swiss Society of Nephrology | Corporate Officer/Principal | ||
| European Society of Hypertension | Treasurer | ||
| Swiss Society of Hypertension | Corporate Officer/Principal | ||
| Dokumed AG | Director/Board Member |
Statistieken
Internationaal
| Zwitserland | 18 |
| Verenigde Staten | 12 |
| Canada | 11 |
| Verenigd Koninkrijk | 4 |
| Denemarken | 3 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Health Services | 3 |
| Miscellaneous | 2 |
Operationeel
| Director/Board Member | 172 |
| Corporate Officer/Principal | 66 |
| Chairman | 52 |
| Chief Executive Officer | 42 |
| Independent Dir/Board Member | 27 |
Sterkste connecties
| Insiders | |
|---|---|
| Paul Geyer | 37 |
| David Ebsworth | 26 |
| Richard Glickman | 26 |
| Sylvie Grégoire | 25 |
| John Montalbano | 22 |
| Simon Pimstone | 22 |
| Jacques Theurillat | 22 |
| Philippe Alexandre Milliet | 18 |
| Heinrich Unger-Krayer | 16 |
| Bruce Cousins | 14 |
| Paul Brennan | 14 |
| Søren Tulstrup | 13 |
| Michel Burnier | 13 |
| Andreas Stefan Walde | 12 |
| Daniela Bosshardt-Hengartner | 11 |
